We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sandoz Gets Warning on Production of Generic Toprol XL
Sandoz Gets Warning on Production of Generic Toprol XL
August 26, 2008
The FDA is questioning a decision by Novartis subsidiary Sandoz to continue distributing generic versions of Toprol XL when the company did not adequately validate its production process.